IP Library Granted Patent US 8,993,298
Granted Patent B1
US 8,993,298 · App. 13/600,408 · Granted Mar 31, 2015

DNA polymerases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,993,298
App. No.
13/600,408
Granted
Mar 31, 2015
Kind
B1
Abstract

Novel proteins having DNA polymerase are described which have utility in amplification reactions and have improved properties over Bst polymerase such as for example enhanced reverse transcriptase activity.

Claims (28)

1. A variant of Bst ( Bacillus stearothermophilus ) polymerase, wherein the variant, that excludes a large fragment Bst polymerase having a wild type sequence with a 289 amino acid truncation deleted from the N-terminal end, is characterized by one or more improved properties for isothermal amplification compared with a wild type Bst polymerase or the large fragment Bst polymerase, selected from the group consisting of:

(a) an increased reaction speed at 65° C., where the increase is at least 10%

(b) an increased temperature stability in the range of 50° C.-100° C.;

(c) an increased salt tolerance in the range of 10 mM-1 M monovalent salt;

(d) an increase in storage stability at 25° C., retaining at least 50% activity over 45 weeks;

(e) an enhanced dUTP tolerance of the range of an increase of 50% to 100% dUTP; or

(f) an increased reverse transcriptase activity by at least 2 fold

wherein the variant polymerase lacks 3′ to 5′ exonuclease activity and comprises an amino acid sequence that has at least 99% identity to a sequence selected from the group consisting of SEQ ID NOs: 43, 47, 48, 65, 75, 85, 86, 111, 112 and 117.

2. A variant according to claim 1 , further comprising DNA polymerase activity.

3. A variant according to claim 1 , wherein the protein is capable of replicating DNA.

4. A variant according to claim 3 , wherein the protein is capable of replicating DNA in an isothermal amplification reaction.

5. A variant according to claim 1 in a storage buffer, or a reaction buffer.

6. A variant according to claim 5 , wherein the buffer further comprises temperature dependent inhibitor of polymerase activity.

7. A variant according to claim 1 , fused to a peptide either directly or by means of a linker.

8. A variant according to claim 5 , wherein the buffer further comprises dNTPs.

9. A variant according to claim 1 , having at least two or three or four or five or six of the improved properties.

10. A DNA encoding the protein of claim 1 .

11. A host cell comprising the DNA according to claim 10 .

12. A method for determining whether a protein according to claim 1 has improved polymerase activity compared with a wild type Bst polymerase; comprising synthesizing a protein according to claim 1 ; and determining the polymerase activity.

13. A method according to claim 12 , wherein characterizing the polymerase activity further comprises: determining in comparison with a wild type Bst polymerase, at last one improved property selected from the group consisting of: thermostability; stability in storage; tolerance to salt; performance in isothermal amplification; strand displacement; kinetics; processivity; fidelity; altered ribonucleotide incorporation; 2′-deoxyuridine 5′-triphosphate incorporation; reverse transcriptase activity; and modified nucleotide incorporation.

14. A method, comprising:

(a) selecting a protein according to claim 1 ; and

(b) expressing the protein as a fusion protein with an additional peptide at an end of the amino acid sequence, the additional peptide attached either directly or by means of a linker.

15. A method of isothermal amplification, comprising:

(a) providing a reaction mixture comprising a protein according to claim 1 , primers and dNTPs;

(b) combining a target DNA with the preparation; and

(c) amplifying the target DNA at a temperature less than 90° C.

16. A method according to claim 15 , wherein the amplification reaction results in a quantitative measure of the amount of target DNA in the preparation.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2012
From: ONG, JENNIFER; EVANS, THOMAS C., JR.; TANNER, NATHAN
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 028896/0659 →